, genetically or non-genetically characterized agammaglobulinemia, common variable immune deficiency, hyper-IgM syndrome, isolated primary IgG deficiency, LRBA or 2 CTL4A deficiency, WHIM syndrome and Good syndrome, hypogammaglobulinemia secondary to hematologic cancer, Kawasaki disease, acute immune thrombocytopenia, chronic immune thrombocytopenia, fetal or neonatal alloimmune thrombocytopenia, immune immunodeficiency, hyper-IgM syndrome, isolated primary IgG deficiency, LRBA or CTL4A deficiency, WHIM syndrome and Good syndrome. Conditions of use: – Yellow level: Priority use. Refer the patient to an immunologist. – Red level: Priority use. Lower the IgG target level to be achieved to the minimum as tolerated on a case-by-case basis and refer the patient to an immunologist. • Secondary